The device company attributes it sales growth to ongoing demand for its VerteBRIDGE Plating Technology, global presence and pipeline of products including the Mobi-C Cervical Artificial Disc.
“Pricing pressures, procedure denials, delayed surgeries and the overall constraints of a down economy all contributed negative pressure in 2010,” said President and CEO Christophe Lavigne. “It is also quite encouraging that we experienced significant growth in key markets outside of the U.S. including Europe, Asia and South America.”
Read the news release about LDR’s sales growth.
Read other coverage about LDR:
– LDR’s VerteBridge Technology Used in 2500 U.S. Spine Surgeries
– 16 Spine Devices Receive FDA 510(k) Clearances in October
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
